Join our mailing list!



Official PayPal Seal

(Your shopping cart is empty)

  Home > Diane Publishing Books >

Prescription Drugs: Trends in FDAs Oversight of Direct-to-Consumer Advertising: Congressional Testimony
The FDA is responsible for overseeing direct-to-co

 
Our Price: $15.00
By Marcia Crosse (au)
Year: 2008
Pages: 15
Binding Paperback

Product Code: 1437905714

Description
 
The FDA is responsible for overseeing direct-to-consumer (DTC) advertising (ad) of prescription drugs, which includes TV, magazines, and the Internet. If FDA identifies a violation of laws or regs. in a DTC ad material, the agency may issue a regulatory letter (RL) asking the drug co. to take specific actions. In 2002, there were delays in FDAs issuance of these RL. This testimony discusses trends in FDAs oversight of DTC ad and the actions FDA has taken when it identifies violations. This statement discusses the: (1) DTC ad materials FDA reviews; (2) FDAs process for issuing RL citing DTC ad materials and the number of RL issued; and (3) the effectiveness of FDAs RL at limiting the dissemination of false or misleading DTC ad. Charts and tables.

Share your knowledge of this product with other customers... Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
1-800-782-3833
 About Us
 Become an Affiliate
 Privacy Policy
 Send Us Feedback
 
Company Info | Advertising | Product Index | Category Index | Help | Terms of Use
Copyright � 2004 Diane Publishing Company. All Rights Reserved.
Built with Volusion